Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H18N2OS |
Molecular Weight | 226.338 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNCC1=C(CSC)C=NC(C)=C1O
InChI
InChIKey=VGWRNXUFWFDSCH-UHFFFAOYSA-N
InChI=1S/C11H18N2OS/c1-4-12-6-10-9(7-15-3)5-13-8(2)11(10)14/h5,12,14H,4,6-7H2,1-3H3
Molecular Formula | C11H18N2OS |
Molecular Weight | 226.338 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tamitinol (also known as EMD 21657), a neurotropic drug that was developed as a cognition enhancer for the treatment of diffuse cerebral disease and organic brain syndrome. Tamitinol participated in clinical trials where the therapeutic effects of the drug were shown to be statistically significant compared to placebo in the global response. However, the treatment was interrupted because of side effects (increased aggressiveness, rash) in 2 cases.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6371575
Patients were randomly assigned to two treatment groups of 50 patients each and received either a neurotropic drug (3 X 200 mg EMD 21657 (Tamitinol)) or placebo coated tablets of identical appearance
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:29:04 GMT 2023
by
admin
on
Fri Dec 15 16:29:04 GMT 2023
|
Record UNII |
9H440NF95E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9H440NF95E
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
SUB10823MIG
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
C016928
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
4735
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
59429-50-4
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
C76784
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
DTXSID30208153
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
CHEMBL307214
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
100000082401
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY | |||
|
3085156
Created by
admin on Fri Dec 15 16:29:04 GMT 2023 , Edited by admin on Fri Dec 15 16:29:04 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |